Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
464 studies found for:    "Uveal diseases"
Show Display Options
Rank Status Study
1 Unknown  Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
Conditions: Behcet Syndrome;   Uveal Disease
Intervention: Drug: Etanercept, Methotrexate, Prednisolone
2 Completed Safety Study of Ranibizumab Eye Injections to Treat Choroidal Neovascularization That Was Caused Other Than by Age-Related Macular Degeneration.
Condition: Choroidal Neovascularization
Intervention: Drug: ranibizumab
3 Recruiting RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma
Condition: Uveal Melanoma
Intervention: Drug: RAD001 (Everolimus) and Pasireotide (SOM230) LAR
4 Active, not recruiting Intravitreal Bevacizumab for the Treatment of CNV in VKH Disease - A Prospective Study
Condition: Choroidal Neovascularization
Intervention: Drug: bevacizumab
5 Withdrawn A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
Condition: Uveitis
Intervention: Device: Iontophoresis second generation Eyegate II device
6 Completed Vaccine Therapy in Treating Patients With Stage IIIB, Stage IIIC, or Stage IV Melanoma
Conditions: Intraocular Melanoma;   Melanoma (Skin)
Interventions: Biological: IFA;   Biological: 6MHP;   Biological: GM-CSF
7 Unknown  Safety and Efficacy of a Heparin-Coated Intraocular Lens in Uveitis
Conditions: Cataract;   Uveitis
Intervention: Device: Heparin Surface-Modified Intraocular Lens
8 Not yet recruiting Trial of AEB071 in Combination With BYL719 in Patients With Melanoma
Condition: Metastatic Uveal Melanoma
Intervention: Drug: AEB071 and BYL719
9 Unknown  A Study of the NeoVista Ophthalmic System for the Treatment of Subfoveal CNV Associated With Wet AMD in Patients That Require Persistent Anti-VEGF Therapy
Condition: Age Related Macular Degeneration
Intervention: Device: NeoVista Ophthalmic System
10 Recruiting Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients
Condition: Uveal Melanoma
Intervention: Biological: autologous dendritic cells electroporated with mRNA
11 Completed Bevicizumab (Avastin) Infusion for Choroidal Neovascularization (CNV) Not Associated With Age-Related Macular Degeneration (AMD)
Conditions: Choroidal Neovascularization;   Degenerative Myopia;   Pathological Myopia
Intervention: Drug: Bevacizumab
12 Recruiting Adjuvant Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy
Condition: Uveal Melanoma
Intervention: Drug: crizotinib
13 Completed Efficacy and Safety of Voclosporin to Treat Active Noninfectious Uveitis
Condition: Noninfectious Uveitis
Intervention: Drug: LX211
14 Unknown  Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
Conditions: Behcet's Disease;   Panuveitis;   Posterior Uveitis;   Retinal Vasculitis
Interventions: Drug: Cyclosporin A;   Drug: Interferon-alpha2a
15 Completed Safety and Efficacy Study of Iontophoresis and Dexamethasone Phosphate to Treat Anterior Uveitis
Condition: Uveitis, Anterior
Interventions: Drug: EGP-437 1.6 mA-min at 0.4 with EyeGate® II System;   Drug: EGP-437 4.8 mA-min at 1.2 mA with EyeGate® II System;   Drug: EGP-437 10.0 mA-min at 2.5 mA with EyeGate® II System;   Drug: EGP-437 14.0 mA-min at 3.5 mA with EyeGate® II System
16 Completed Gene Therapy for Gyrate Atrophy
Condition: Gyrate Atrophy
Intervention: Procedure: Gene therapy
17 Unknown  LOXL1 Polymorphism in Pseudoexfoliation Syndrome
Condition: Pseudoexfoliation Syndrome
Intervention:
18 Completed Flare Photometry in Uveitis Patients
Condition: Uveitis
Intervention:
19 Recruiting Addition of 20mg/Day Zeaxanthin to Triple Therapy Treatment Options for Age Related Macular Degeneration (ARMD)
Condition: Exudative Age-Related Macular Degeneration
Intervention:
20 Unknown  Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration
Condition: Neovascular Age Related Macular Degeneration
Intervention: Biological: iSONEP

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years